Literature DB >> 16493571

[Prophylactic influenza vaccination: what is the situation in Germany?].

P Wutzler1.   

Abstract

Vaccination is the most efficacious and cost-effective measure for the prevention of influenza. Although the vaccination rate among the population of Germany has been gradually increasing in the last few years, only 40% of chronically ill persons are vaccinated. As a third of all persons aged over 50 years have a chronic disease, vaccination of those aged 50 years and over, from the those recommended 60 years, should be considered. Such a strategy would be cost-effective both for insurance companies and society as a whole. There are at present no data on ambulatory influenza vaccination rates in children, even though this could reduce the high death rate among this age group and decrease the spread of the disease among the general population. At present all children with an underlying disease and all those in immediate contact with them should be vaccinated. Pregnant women whose expected date of delivery falls within the influenza season should also be vaccinated so that they and their newborn child are protected against influenza.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493571     DOI: 10.1055/s-2006-932543

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

Review 1.  Vaccination against classical influenza in health-care workers: self-protection and patient protection.

Authors:  Sabine Wicker; Holger F Rabenau; Volkhard A J Kempf; Christian Brandt
Journal:  Dtsch Arztebl Int       Date:  2009-09-04       Impact factor: 5.594

2.  [Health in older age: cost of illness and cost-effectiveness of prevention].

Authors:  I Brandes; U Walter
Journal:  Z Gerontol Geriatr       Date:  2007-08       Impact factor: 1.281

3.  Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.

Authors:  Oliver Damm; Martin Eichner; Markus Andreas Rose; Markus Knuf; Peter Wutzler; Johannes Günter Liese; Hagen Krüger; Wolfgang Greiner
Journal:  Eur J Health Econ       Date:  2014-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.